Intas Brings India’s First Needle-Free Injection T...
Category : Clinical Trial Update 30 December 2025Foresee Pharmaceuticals has announced positive topline results from its Phase 3 Casppian clinical tr...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Edgewise Therapeutics Reports Positive Phase 2 Pro...
Category : Clinical Trial Update 30 December 2025Edgewise Therapeutics has shared encouraging interim updates from its ongoing CIRRUS-HCM Phase 2 tri...
Foresee Pharmaceuticals Reports Positive Phase 3 R...
Category : Clinical Trial Update 30 December 2025Foresee Pharmaceuticals has announced positive topline results from its Phase 3 Casppian clinical tr...
GC Biopharma Gets South Korea Approval to Start Ph...
Category : Clinical Trial Update 29 December 2025GC Biopharma has received regulatory clearance in South Korea to begin human testing of its mRNA-bas...
IRLAB Secures Approvals for Phase Ib Study of Firs...
Category : Clinical Trial Update 27 December 2025IRLAB, a Sweden-headquartered biotech focused on Parkinson’s disease, has received regulatory...
Latest Newsletter Post
-
Foresee Pharmaceuticals Reports Pos..
30 December 2025
-
Edgewise Therapeutics Reports Posit..
30 December 2025
-
Intas Brings India’s First Needle-F..
30 December 2025
-
GC Biopharma Gets South Korea Appro..
29 December 2025
-
Johnson & Johnson Halts Development..
27 December 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com